Cancer Center of Middle Georgia

Dublin, Georgia 31021

3 studies enrolling now · 6 studies all time

What they study most

Breast Cancer, Cancer, Chemotherapy-induced Neutropenia, Early Detection of Cancer, Immune Checkpoint Therapy, Immunotherapy, Minimal Residual Disease, Neuropathic Pain, Neutropenia, PD-1, PD-L1, Pain

Studies at this site

• Prospective Study to Assess a Diagnostic Aid for Cancer — Recruiting now
• Caris Biorepository Research Protocol — Recruiting now
• A Prospective Real World Evidence Study (PROWES) for Concordance Rate of Blood-based 3D Genome Conformation Mapping (Episwitch CiRT®) to Identify Likelihood of Response and Actual Response Rates to PD-(L)-1 Checkpoint Inhibitors Across Multiple Oncological Indications. — Recruiting now
• Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Phase 2 — Completed
• SPI-2012 vs Pegfilgrastim in Management of Neutropenia in Breast Cancer Participants With Docetaxel and Cyclophosphamide — Completed
• The Purpose of This Study is to Determine if Tetrodotoxin (TTX) is Effective in the Treatment of Pain Resulting From Chemotherapy Treatment — Stopped early